Liver disease is the fifth largest cause of mortality in England and Wales, after heart disease, cancer, stroke and respiratory disease. In the UK,...

On June 21st 2015, an announcement was made by the Department of Health and the UK Public Health Minister that the Meningococcal B (MenB)...

Social Prescribing: What is it? ‘Social prescribing,’ or ‘community referral,’ is a way of linking patients in primary care with sources of support within the...

On 23rd October 2014, NHS England published its Five Year Forward View, which began with the statement (1,2): ‘the NHS is at a crossroads and...

In May 2015, a molecular microbiology study was published in the Proceedings of the National Academy of Sciences (1). This study showed that gut...

  It is a truth, universally acknowledged by healthcare professionals, that an interesting and innovative medical research finding can become sensationalised with its ‘passage’ through...

FDA Approval of the Nasal Alar SpO2 Sensor On the 18th of March 2015, Xhale Assurance, developer of the patented Assurance® Nasal Alar SpO2™ Sensor,...

The Gram-negative bacterial family of Enterobacteriaceae, includes the species Klebsiella, Enterobacter, and Escherichia. These bacteria can cause opportunistic wound infections, gastroenteritis, pneumonia and septicaemia,...

The NHS is the fifth largest employer in the world. In the UK, the public healthcare industry spends nearly £40 billion per year on commissioning its health services for local people. This year, the procurement of NHS goods and services have been reviewed and concerns have been raised.